OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Histamine may contribute to vortioxetine's procognitive effects; possibly through an orexigenic mechanism
Gennady Smagin, Dekun Song, David P. Budac, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2016) Vol. 68, pp. 25-30
Closed Access | Times Cited: 14
Gennady Smagin, Dekun Song, David P. Budac, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2016) Vol. 68, pp. 25-30
Closed Access | Times Cited: 14
Showing 14 citing articles:
Vortioxetina: una nueva alternativa en el trastorno depresivo mayor
Estela Salagre, Iría Grande, Brisa Solé, et al.
Revista de Psiquiatría y Salud Mental (2017) Vol. 11, Iss. 1, pp. 48-59
Closed Access | Times Cited: 34
Estela Salagre, Iría Grande, Brisa Solé, et al.
Revista de Psiquiatría y Salud Mental (2017) Vol. 11, Iss. 1, pp. 48-59
Closed Access | Times Cited: 34
Vortioxetine improved negative and cognitive symptoms of schizophrenia in subchronic MK-801 model in rats
Nuh Mehmet Bozkurt, Gökhan Ünal
Behavioural Brain Research (2023) Vol. 444, pp. 114365-114365
Closed Access | Times Cited: 10
Nuh Mehmet Bozkurt, Gökhan Ünal
Behavioural Brain Research (2023) Vol. 444, pp. 114365-114365
Closed Access | Times Cited: 10
Vortioxetine Treatment Reverses Subchronic PCP Treatment-Induced Cognitive Impairments: A Potential Role for Serotonin Receptor-Mediated Regulation of GABA Neurotransmission
Alan L. Pehrson, Christian Sejer Pedersen, K.S. Tølbøl, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 30
Alan L. Pehrson, Christian Sejer Pedersen, K.S. Tølbøl, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 30
Vortioxetine: A new alternative for the treatment of major depressive disorder
Estela Salagre, Iría Grande, Brisa Solé, et al.
Revista de Psiquiatría y Salud Mental (English Edition) (2018) Vol. 11, Iss. 1, pp. 48-59
Closed Access | Times Cited: 29
Estela Salagre, Iría Grande, Brisa Solé, et al.
Revista de Psiquiatría y Salud Mental (English Edition) (2018) Vol. 11, Iss. 1, pp. 48-59
Closed Access | Times Cited: 29
Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update
Daniela Adamo, Elena Calabria, Noemi Coppola, et al.
Therapeutic Advances in Psychopharmacology (2021) Vol. 11
Open Access | Times Cited: 18
Daniela Adamo, Elena Calabria, Noemi Coppola, et al.
Therapeutic Advances in Psychopharmacology (2021) Vol. 11
Open Access | Times Cited: 18
The mechanism of different orexin/hypocretin neuronal projections in wakefulness and sleep
Nanxi Li, Lishan Huang, Bin Zhang, et al.
Brain Research (2024), pp. 149408-149408
Open Access | Times Cited: 1
Nanxi Li, Lishan Huang, Bin Zhang, et al.
Brain Research (2024), pp. 149408-149408
Open Access | Times Cited: 1
Insights into the advances in therapeutic drugs for neuroinflammation-related diseases
B. Luo
International Journal of Neuroscience (2023), pp. 1-26
Closed Access | Times Cited: 3
B. Luo
International Journal of Neuroscience (2023), pp. 1-26
Closed Access | Times Cited: 3
Partial inhibition of catecholamine activity and enhanced responsiveness to NMDA after sustained administration of vortioxetine
Mohammad Ali Ebrahimzadeh, Mostafa El Mansari, Pierre Blier
Neuropharmacology (2017) Vol. 128, pp. 425-432
Open Access | Times Cited: 9
Mohammad Ali Ebrahimzadeh, Mostafa El Mansari, Pierre Blier
Neuropharmacology (2017) Vol. 128, pp. 425-432
Open Access | Times Cited: 9
Vortioxetine in management of major depressive disorder – a favorable alternative for elderly patients?
Dorota Danielak
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 9, pp. 1167-1177
Closed Access | Times Cited: 8
Dorota Danielak
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 9, pp. 1167-1177
Closed Access | Times Cited: 8
Role of vortioxetine in the treatment of neuropathic pain
A. Alcántara Montero, S.R. Pacheco de Vasconcelos
Revista Española de Anestesiología y Reanimación (English Edition) (2022) Vol. 69, Iss. 10, pp. 640-648
Closed Access | Times Cited: 5
A. Alcántara Montero, S.R. Pacheco de Vasconcelos
Revista Española de Anestesiología y Reanimación (English Edition) (2022) Vol. 69, Iss. 10, pp. 640-648
Closed Access | Times Cited: 5
Vortioxetine improved social and cognitive deficits in acute ketamine model of schizophrenia in rats
Gökhan Ünal, Mehmet Taşkıran
Journal of Research in Pharmacy (2020) Vol. 24, Iss. 5, pp. 648-655
Open Access | Times Cited: 6
Gökhan Ünal, Mehmet Taşkıran
Journal of Research in Pharmacy (2020) Vol. 24, Iss. 5, pp. 648-655
Open Access | Times Cited: 6
Papel de vortioxetina en el tratamiento del dolor neuropático
A. Alcántara Montero, S.R. Pacheco de Vasconcelos
Revista Española de Anestesiología y Reanimación (2021) Vol. 69, Iss. 10, pp. 640-648
Closed Access | Times Cited: 4
A. Alcántara Montero, S.R. Pacheco de Vasconcelos
Revista Española de Anestesiología y Reanimación (2021) Vol. 69, Iss. 10, pp. 640-648
Closed Access | Times Cited: 4
Εfficacy and safety of vortioxetine (Lu AA21004) in the treatment of adult patients with major depressive disorder: A systematic review and a meta‑analysis of randomized controlled trials
Shan Gao, Xingxing Xie, Ling Fan, et al.
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 5
Open Access | Times Cited: 1
Shan Gao, Xingxing Xie, Ling Fan, et al.
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 5
Open Access | Times Cited: 1
